Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
Programmed death 1 (PD-1) and its two natural ligands PD-L1 and PD-L2 are responsible for delivering inhibitory signals that regulate the balance between T cell activation, tolerance, and immunopathology. In previous studies, PD-1 was found only expressed on the surface of immune cells, such as T ce...
Main Authors: | Han Yao, Huanbin Wang, Chushu Li, Jing-Yuan Fang, Jie Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01774/full |
Similar Items
-
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
by: Luisa Chocarro de Erauso, et al.
Published: (2020-04-01) -
Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
by: Ivan Shevchenko, et al.
Published: (2018-08-01) -
Advanced Research of mTOR and Lung Carcinoid Tumors
by: Zixuan ZHANG, et al.
Published: (2013-01-01) -
Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy
by: Jie Chen, et al.
Published: (2022-01-01) -
Huge soft tissue PEComa with aggressive lung and bone metastases
by: Shih-Hao Tang, et al.
Published: (2017-09-01)